Boswellia

References

1. ^ a b Tawab MA, et al. Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma. J Chromatogr B Biomed Sci Appl. (2001)
2. ^ Woolley CL, et al. Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry. J Chromatogr A. (2012)
3. ^ de Rapper S, et al. The additive and synergistic antimicrobial effects of select frankincense and myrrh oils–a combination from the pharaonic pharmacopoeia. Lett Appl Microbiol. (2012)
4. ^ Blain EJ, Ali AY, Duance VC. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage. Phytother Res. (2010)
5. ^ Devi PR, et al. Safety Evaluation of Alcoholic Extract of Boswellia ovalifoliolata Stem-bark in Rats. Toxicol Int. (2012)
6. ^ a b c Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. (2011)
7. ^ a b c d e f g h Gerbeth K, et al. Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometry. J Pharm Biomed Anal. (2011)
8. ^ a b c d e f g h i j k l Moussaieff A, et al. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J. (2008)
9. ^ Al-Harrasi A, Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban). Molecules. (2008)
10. ^ a b Wang C, et al. Determination of five boswellic acids in Boswellia serrata. Zhongguo Zhong Yao Za Zhi. (2011)
11. ^ a b c Büchele B, Simmet T. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J Chromatogr B Analyt Technol Biomed Life Sci. (2003)
12. ^ a b c d e f g h Moussaieff A, et al. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals. J Psychopharmacol. (2012)
13. ^ Paul M, Jauch J. Efficient preparation of incensole and incensole acetate, and quantification of these bioactive diterpenes in Boswellia papyrifera by a RP-DAD-HPLC method. Nat Prod Commun. (2012)
14. ^ a b c Bhushan S, et al. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis. (2007)
15. ^ a b c Bhushan S, et al. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata. Mol Carcinog. (2009)
16. ^ Schmidt TJ, Kaiser M, Brun R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activity. Planta Med. (2011)
17. ^ Two triterpenoids from Boswellia serrata gum resin.
18. ^ TETRACYCLIC TRITERPENE ACIDS FROM RESIN OF BOSWELLIA-SERRATA ROXB.
19. ^ Song Z, et al. Determination of alpha-pinene and octyl acetate contents in Boswellia serrata. Zhongguo Zhong Yao Za Zhi. (2012)
20. ^ a b c d e f Khajuria A, et al. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata. Phytother Res. (2008)
21. ^ The structure of incensole.
22. ^ a b c d Roy S, et al. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia. Antioxid Redox Signal. (2006)
23. ^ Sengupta K, et al. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem. (2011)
24. ^ a b c d e f g Takada Y, et al. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. (2006)
25. ^ Kumar A, et al. Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl). (2004)
26. ^ Ozes ON, et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. (1999)
27. ^ Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. (2002)
28. ^ Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicine. Pharmacol Biochem Behav. (2002)
29. ^ Trojanowski JQ, et al. Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments. Expert Opin Pharmacother. (2005)
30. ^ Nelson R. Microtubule-stabilising drugs may be therapeutic in AD. Lancet Neurol. (2005)
31. ^ Avila J, et al. Role of tau protein in both physiological and pathological conditions. Physiol Rev. (2004)
32. ^ a b Karima O, et al. An in vitro study of the role of β-boswellic acid in the microtubule assembly dynamics. FEBS Lett. (2012)
33. ^ a b Karima O, et al. The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study). Neurol Sci. (2010)
34. ^ Krüger P, et al. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur J Pharm Sci. (2009)
35. ^ Krishna G, et al. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int J Pharm. (2001)
36. ^ a b c d e f g h Gerbeth K, et al. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia. (2012)
37. ^ a b c d e f g h i Hüsch J, et al. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract. Fitoterapia. (2012)
38. ^ Hüsch J, et al. Effect of Phospholipid-Based Formulations of Boswellia serrata Extract on the Solubility, Permeability, and Absorption of the Individual Boswellic Acid Constituents Present. J Nat Prod. (2012)
39. ^ Sharma A, Gupta NK, Dixit VK. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv. (2010)
40. ^ a b c Reising K, et al. Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem. (2005)
41. ^ a b c Tausch L, et al. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. J Immunol. (2009)
42. ^ Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. (2004)
43. ^ a b c d Skarke C, et al. Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures. J Clin Pharmacol. (2012)
44. ^ a b Siemoneit U, et al. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance. Eur J Pharmacol. (2009)
45. ^ Krüger P, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos. (2008)
46. ^ Weber CC, et al. Modulation of Pgp function by boswellic acids. Planta Med. (2006)
47. ^ Chung MK, et al. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J Biol Chem. (2004)
48. ^ Xu H, et al. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature. (2002)
49. ^ Smith GD, et al. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature. (2002)
50. ^ a b Bakthira H, et al. Anticholinesterase activity of endemic plant extracts from Soqotra. Afr J Tradit Complement Altern Med. (2011)
51. ^ a b c Moussaieff A, et al. Protective effects of incensole acetate on cerebral ischemic injury. Brain Res. (2012)
52. ^ a b c Streffer JR, et al. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology. (2001)
53. ^ a b c Winking M, et al. Boswellic acids inhibit glioma growth: a new treatment option. J Neurooncol. (2000)
54. ^ Lampl C, Haider B, Schweiger C. Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache. Cephalalgia. (2012)
55. ^ Leroux E, Ducros A. Cluster headache. Orphanet J Rare Dis. (2008)
56. ^ a b Mahmoudi A, et al. Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats. J Nat Med. (2011)
57. ^ Roy S, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. (2005)
58. ^ a b c Cuaz-Pérolin C, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice. Arterioscler Thromb Vasc Biol. (2008)
59. ^ a b c d e f g h Sengupta K, et al. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci. (2010)
60. ^ The IκB Kinase (IKK) Inhibitor, NEMO-binding Domain Peptide, Blocks Osteoclastogenesis and Bone Erosion in Inflammatory Arthritis.
61. ^ Abu-Amer Y, Tondravi MM. NF-kappaB and bone: the breaking point. Nat Med. (1997)
62. ^ Kulkarni RR, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol. (1991)
63. ^ Chopra A, et al. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol. (2000)
64. ^ a b Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci. (2011)
65. ^ a b Sengupta K, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. (2008)
66. ^ a b Gupta PK, et al. Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis). Ayu. (2011)
67. ^ Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. (2007)
68. ^ Cassileth B. Complementary therapies, herbs, and other OTC agents: Boswellia (Boswellia serrata). Oncology (Williston Park). (2009)
69. ^ Martínez-Clemente M, Clària J, Titos E. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. Curr Opin Clin Nutr Metab Care. (2011)
70. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. (1997)
71. ^ a b Sailer ER, et al. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol. (1996)
72. ^ Safayhi H, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. (1992)
73. ^ Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol. (1995)
74. ^ Ammon HP, et al. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. (1993)
75. ^ Siemoneit U, et al. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol. (2008)
76. ^ a b c d Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. (2010)
77. ^ Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem. (2006)
78. ^ Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo.
79. ^ a b Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases.
80. ^ a b c d e Henkel A, et al. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference. Biochem Pharmacol. (2012)
81. ^ Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. (1976)
82. ^ Moussaieff A, et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol Pharmacol. (2007)
83. ^ Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol. (2006)
84. ^ a b Siemoneit U, et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol. (2011)
85. ^ Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. (2007)
86. ^ Verhoff M, et al. A novel C(28)-hydroxylated lupeolic acid suppresses the biosynthesis of eicosanoids through inhibition of cytosolic phospholipase A(2). Biochem Pharmacol. (2012)
87. ^ a b c Safayhi H, et al. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. (1997)
88. ^ a b Kapil A, Moza N. Anticomplementary activity of boswellic acids–an inhibitor of C3-convertase of the classical complement pathway. Int J Immunopharmacol. (1992)
89. ^ a b c d e Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) from Boswellia serrata.
90. ^ Khajuria A, et al. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine. (2007)
91. ^ a b Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood.
92. ^ a b Shehata AM, et al. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE). Phytomedicine. (2011)
93. ^ a b c d e Yuan HQ, et al. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Biochem Pharmacol. (2008)
94. ^ Rollinger JM, et al. 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches. Bioorg Med Chem. (2010)
95. ^ a b Borrelli F, et al. Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation. Br J Pharmacol. (2006)
96. ^ a b Latella G, et al. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest. (2008)
97. ^ Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitis. Saudi J Gastroenterol. (2012)
98. ^ a b Hartmann RM, et al. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid. Dig Dis Sci. (2012)
99. ^ a b Anthoni C, et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. (2006)
100. ^ Rhodes JM, et al. Serum inhibitors of leukocyte chemotaxis in Crohn’s disease and ulcerative colitis. Gastroenterology. (1982)
101. ^ Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. (2008)
102. ^ Madisch A, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis. (2007)
103. ^ Slonim AE, Grovit M, Bulone L. Effect of exclusion diet with nutraceutical therapy in juvenile Crohn’s disease. J Am Coll Nutr. (2009)
104. ^ a b c Holtmeier W, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn’s disease: good safety profile but lack of efficacy. Inflamm Bowel Dis. (2011)
105. ^ a b Raja AF, et al. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes. (2011)
106. ^ Schillaci D, et al. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. Lett Appl Microbiol. (2008)
107. ^ a b Mahmoud MF, Diaai AA, Ahmed F. Evaluation of the efficacy of ginger, Arabic gum, and Boswellia in acute and chronic renal failure. Ren Fail. (2012)
108. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. (1998)
109. ^ Clark CE, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J. (2010)
110. ^ a b Houssen ME, et al. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma. Clin Biochem. (2010)
111. ^ a b Lakka A, et al. Isolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymer. Invest New Drugs. (2011)
112. ^ Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. (2002)
113. ^ Belozerov VE, Van Meir EG. Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs. (2005)
114. ^ a b c d e f Pang X, et al. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res. (2009)
115. ^ a b c Hoernlein RF, et al. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J Pharmacol Exp Ther. (1999)
116. ^ Castelli S, et al. Interaction between natural compounds and human topoisomerase I. Biol Chem. (2012)
117. ^ On the expression and regulation of 5-lipoxygenase in human lymphocytes.
118. ^ a b c d Glaser T, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer. (1999)
119. ^ Glioblastoma multiforme: Morphology and biology.
120. ^ a b Flavin DF. A lipoxygenase inhibitor in breast cancer brain metastases. J Neurooncol. (2007)
121. ^ Shen Y, et al. Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. Cancer Biol Ther. (2012)
122. ^ a b Takahashi M, et al. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis. (2012)
123. ^ Liu JJ, Duan RD. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. Anticancer Res. (2009)
124. ^ Liu HP, et al. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Int J Cancer. (2012)
125. ^ Suh J, et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. (2002)
126. ^ Büchele B, et al. Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo. Planta Med. (2006)
127. ^ Lu M, et al. Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Cancer Res. (2008)
128. ^ Kim HR, et al. Bosellia serrata-induced apoptosis is related with ER stress and calcium release. Genes Nutr. (2008)
129. ^ Khan S, et al. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death. Eur J Pharmacol. (2011)
130. ^ Kaur R, et al. A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acid. Eur J Med Chem. (2011)
131. ^ a b Aggarwal BB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. (2006)
132. ^ Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression.
133. ^ a b c d Kunnumakkara AB, et al. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol Cancer Res. (2009)
134. ^ Gene Silencing of the Tyrosine Phosphatase SHP1 Gene by Aberrant Methylation in Leukemias/Lymphomas.
135. ^ a b c d e f g Park B, et al. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int J Cancer. (2011)
136. ^ Suhail MM, et al. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern Med. (2011)
137. ^ Mothana RA, et al. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med. (2009)
138. ^ Koshiba T, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res. (2000)
139. ^ a b c d e Park B, et al. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PLoS One. (2011)
140. ^ Ni X, et al. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complement Altern Med. (2012)
141. ^ Safayhi H, Sailer ER. Anti-inflammatory actions of pentacyclic triterpenes. Planta Med. (1997)
142. ^ a b c Pedretti A, et al. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study. Planta Med. (2010)
143. ^ a b Calzavara-Pinton P, et al. Topical Boswellic acids for treatment of photoaged skin. Dermatol Ther. (2010)
144. ^ a b Krishnaraju AV, et al. Safety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory product. Toxicol Mech Methods. (2010)
145. ^ Tripathi YB. BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Recent Pat Inflamm Allergy Drug Discov. (2009)
146. ^ a b c d Su S, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J Ethnopharmacol. (2012)
147. ^ a b Sferra R, et al. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation. Eur Rev Med Pharmacol Sci. (2012)
148. ^ a b Lalithakumari K, et al. Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R)). Toxicol Mech Methods. (2006)
149. ^ Lupi S, et al. Mutagenicity evaluation with Ames test of hydro-alcoholic solution of terpenes. J Prev Med Hyg. (2009)
150. ^ Sharma R, et al. In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodents. Phytomedicine. (2009)
151. ^ Acebo E, et al. Allergic contact dermatitis from Boswellia serrata extract in a naturopathic cream. Contact Dermatitis. (2004)